SCHEMBL2615467

SCHEMBL2615467

CC(C)(Oc1ccc(F)cc1)C(=O)OCCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 10/20 0.65
CYP1A2 P05177 3/20 0.65
CYP3A4 P08684 3/20 0.65
ABCB11 O95342 2/20 0.65
TSHR P16473 2/20 0.65
HTR2A P28223 2/20 0.65
PMP22 Q01453 2/20 0.65
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
MAPT P10636 2/20 0.53
CYP2C19 P33261 2/20 0.53
CYP2D6 P10635 1/20 0.53
PPARG P37231 5/20 0.49
PPARD Q03181 4/20 0.49
CNR1 P21554 3/20 0.48
HPGD P15428 2/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Simfibrate SCHEMBL27667 0.93 PPARA (0.74) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL13284875 0.93 PPARA (0.53) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL2615466 0.87 PPARA (0.51) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL30231731 0.87 PPARA (0.75) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL28102603 0.84 PPARA (0.67) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL28102602 0.83 PPARA (0.65) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL11640865 0.82 PPARA (0.72) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL11641659 0.82 PPARA (0.72) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL28882728 0.82 PPARA (0.63) PPARACYP1A2CYP3A4ABCB11TSHR
SCHEMBL11739630 0.81 PPARA (0.70) PPARACYP1A2CYP3A4ABCB11TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed
WO-2010081036-A2 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF FLI1, CDC73, FOS PPARA 1435/4885CYP1A2 1410/4885CYP3A4 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.